Induction of DNA synthesis in mouse liver following increases of DNA adduct levels elicited by very low cumulative doses of the genotoxic hepatocarcinogen 7H-dibenzo[c,g]carbazole

Toxicologic Pathology

Volumn 29, Issue 5, 2001, Pages 528-534

  Dorchies, O ^a   Perin Roussel, O ^a   Gillardeaux, O ^a   Vericat, J A ^a   Roome, N O ^a   Prenez, A ^a   Perin, F ^a  

^a SANOFI   (France)

Author keywords

Carcinogenesis; Dibenzo c,g carbazole; DNA adducts; DNA synthesis; Mouse liver; Risk assessment

Indexed keywords

7H DIBENZO[C,G]CARBAZOLE; CARBAZOLE DERIVATIVE; CELL DNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER RISK; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DNA ADDUCT; DNA SYNTHESIS; FEMALE; GENOTOXICITY; HISTOPATHOLOGY; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT;

ADMINISTRATION, TOPICAL; ANIMALS; APOPTOSIS; CARBAZOLES; CARCINOGENS; CELL DIVISION; DNA ADDUCTS; DNA REPLICATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEPATOCYTES; LIVER; MICE; MICE, INBRED DBA; MUTAGENS;

ANIMALIA;

EID: 0034761695     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/019262301317226320     Document Type: Article

References (40)

1. Too many rodent carcinogens: Mitogenesis increases, mutagenesis
2. Squamous carcinoma of the forestomach and other lesions in mice following oral administration of 3,4,5,6-dibenzocarbazole
3. Changes in the livers of mice after administration of 3,4,5,6-dibenzocarbazole
4. A strategy for establishing mode of action of chemicals carcinogens as a guide for approaches to risk assessment
5. The potential role of chemically induced hyperplasia in the carcinogenic activity of the hypolipidemic carcinogens
6. Initiation of chemical carcinogenesis requires cell proliferation
7. Sequential events in chemical carcinogenesis
8. Tumors and DNA adducts in mice exposed to benzo[a]pyrene and coal tars; implications for risk assessment
9. Guidelines for measuring chemically induced cell proliferation in specific rodent target organs. Chemically induced cell proliferation: Implications for risk assessment
10. Nonrandom binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo
11. 32P-postlabeling analysis of nonradioactive aromatic carcinogen-DNA adducts
12. Hepatocyte proliferation and serum hepatocyte growth factor levels in patients with alcoholic hepatitis
13. Regeneration of transplanted human liver: Gene expression at the time of graft implantation
14. Certain polycyclic aromatic hydrocarbons and heterocyclic compounds
15. Measures of cell replication in risk/safety assessment of xenobiotic-induced, non genotoxic carcinogenesis
16. 32P]cGMP, and their use in the assay of adenylate and guanylate cyclases and cyclic nucleotide phosphodiesterases
17. Expression of hepatocytes growth factor, transforming growth factor alpha, transforming growth factor beta 1 messenger RNA in various human liver diseases and correlation with hepatocyte proliferation
18. Comparison of blood protein and target organ DNA and protein binding following topical application of benzo[a]pyrene and 7H-dibenzo[c,g]carbazole to mice
19. Heterocyclic polycyclic aromatic hydrocarbon carcinogenesis: 7H-dibenzo[c,g]carbazole metabolism by microsomal enzymes from mouse and rat liver
20. Inversion of genetic predisposition to carcinogenesis in liver of two lines of mice selected for resistance (Car-R) or susceptibility (Car-S) to skin carcinogenesis
21. Organspecific, carcinogenic dibenzo[c,g]carbazole derivatives: Discriminative response in S. typhimurium TA100 mutagenesis modulated by subcellular fractions of mouse liver
22. Tissue specific differences in adduct formation by hepatocarcinogenic and sarcomagenic derivatives of 7H-dibenzo[c,g]carbazole in mouse parenchymal and nonparenchymal liver cells
23. Interaction of 7H-dibenzo[c,g]carbazole and its organospecific derivatives with hepatic mitochondrial and nuclear DNA in mouse
24. Current data and questions on the carcinogenicity of solid particles of diesel engine exhaust and other sources
25. Repeated partial hepatectomy as a promoting stimulus for carcinogenic response of liver to nitrosamines in rat
26. Increased cell division as a cause of human cancer
27. 32P-Postlabeling analysis of DNA adducts persisting for up to 42 weeks in the skin epidermis and dermis of mice treated topically with 7,12-dimethylbenz[a]anthracene
28. 32P-postlabeling assay and possible significance for spontaneous tumor induction and aging
29. 32P-Postlabeling test for covalent DNA binding of chemicals in vivo: Application to a variety of aromatic carcinogens and methylating agents
30. 32P-Postlabeling test for structurally diverse DNA adducts
31. TMMouse liver and skin
32. Tumor induction by 7H-dibenzo[c,g]carbazole in the respiratory tract of Syrian hamsters
33. Effect of partial hepatectomy on the formation and elimination of 3-methyl-dibenzo[c,g]carbazole-DNA adducts in mouse liver
34. Tissue distribution of DNA adducts of 7H-dibenzo [c,g]carbazole and its derivatives in mice following topical administration
35. TMMice treated with 5,9-dimethyldibenzo[c,g]-carbazole
36. TMMice treated with 5,9-dimethyl[c,g]dibenzocarbazole
37. Sexual differences in the expression of gamma-glutamyl transpeptidase during 5,9-dimethyldibenzocarbazole-induced hepatocarcinogenesis in mice
38. Binding of 5,9-dimethyldibenzo[c,g]-carbazole, a potent hepatocarcinogen, to mouse hepatic cytosolic proteins
39. Environmental sources, carcinogenicity, mutagenicity, metabolism and DNA binding of nitrogen and sulfur heterocyclic aromatics
40. Comparative carcinogenicity, metabolism, mutagenicity, and DNA binding of 7H-dibenzo-[c,g]carbazole and dibenzo [a,j] acridine